Wuhan Keqian Biology to Co-Develop Feline Quadrivalent Vaccine with University

MT Newswires Live03-25

Wuhan Keqian Biology (SHA:688526) will collaborate with Huazhong Agricultural University to develop a feline quadrivalent inactivated and feline mycoplasma inactivated vaccines, according to a Wednesday filing with the Shanghai bourse.

The quadrivalent feline vaccines will target feline panleukopenia virus, feline calicivirus, feline herpesvirus, and feline mycoplasma, the filing said.

Under the research and collaboration agreement, the listed company will pay the university 1 million yuan, with the research results to be jointly owned by both the company and the university.

Huazhong Agricultural University subsidiary Wuhan Huazhong Agricultural University Asset Management holds 16.73% of the listed company's shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2622202680?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-25 19:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622202680","market":"nz","top_or_hot":-1,"title":"Wuhan Keqian Biology to Co-Develop Feline Quadrivalent Vaccine with University","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/688526\">Wuhan Keqian Biology</a> (SHA:688526) will collaborate with Huazhong Agricultural University to develop a feline quadrivalent inactivated and feline mycoplasma inactivated vaccines, according to a Wednesday filing with the Shanghai bourse.</p><p>The quadrivalent feline vaccines will target feline panleukopenia virus, feline calicivirus, feline herpesvirus, and feline mycoplasma, the filing said.</p><p>Under the research and collaboration agreement, the listed company will pay the university 1 million yuan, with the research results to be jointly owned by both the company and the university.</p><p>Huazhong Agricultural University subsidiary Wuhan Huazhong Agricultural University Asset Management holds 16.73% of the listed company's shares.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wuhan Keqian Biology to Co-Develop Feline Quadrivalent Vaccine with University</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWuhan Keqian Biology to Co-Develop Feline Quadrivalent Vaccine with University\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-03-25 19:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/688526\">Wuhan Keqian Biology</a> (SHA:688526) will collaborate with Huazhong Agricultural University to develop a feline quadrivalent inactivated and feline mycoplasma inactivated vaccines, according to a Wednesday filing with the Shanghai bourse.</p><p>The quadrivalent feline vaccines will target feline panleukopenia virus, feline calicivirus, feline herpesvirus, and feline mycoplasma, the filing said.</p><p>Under the research and collaboration agreement, the listed company will pay the university 1 million yuan, with the research results to be jointly owned by both the company and the university.</p><p>Huazhong Agricultural University subsidiary Wuhan Huazhong Agricultural University Asset Management holds 16.73% of the listed company's shares.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688526","symbol_name":"科前生物","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2622202680","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2622202680","pubTimestamp":1774437726,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Wuhan Keqian Biology (SHA:688526) will collaborate with Huazhong Agricultural University to develop a feline quadrivalent inactivated and feline mycoplasma inactivated vaccines, according to a Wednesd","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"688526":"科前生物","BK0239":"医药制造"},"translate_title":"武汉科前生物将与大学合作开发猫科四价疫苗","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688526":0.9},"content_text":"Wuhan Keqian Biology (SHA:688526) will collaborate with Huazhong Agricultural University to develop a feline quadrivalent inactivated and feline mycoplasma inactivated vaccines, according to a Wednesday filing with the Shanghai bourse.The quadrivalent feline vaccines will target feline panleukopenia virus, feline calicivirus, feline herpesvirus, and feline mycoplasma, the filing said.Under the research and collaboration agreement, the listed company will pay the university 1 million yuan, with the research results to be jointly owned by both the company and the university.Huazhong Agricultural University subsidiary Wuhan Huazhong Agricultural University Asset Management holds 16.73% of the listed company's shares.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2622202680","isCrawlerRequest":true}